查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574054

体外诊断的全球市场:2024-2034年

In Vitro Diagnostics Market Report 2024-2034
出版日期: | 出版商: Visiongain | 英文 367 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2034 年，全球体外诊断市场规模将以 6.7% 的复合年增长率成长。

科技进步推动产业发展

诊断技术更高的准确性、便携性和更低的价格极大地支持了市场成长。在先进且高度准确的临床实验室测试的推动下，创新体外诊断 (IVD) 测试的采用正在蓬勃发展。例如，2023年6月，日本厚生劳动省批准了东丽的胰臟癌诊断工具 "东丽APOA2-iTQ" 。同样在 2023 年 3 月，美国 FDA 批准了雅培针对创伤性脑损伤 (TBI) 的开创性血液检测。这些针对重要健康状况的尖端体外诊断技术的成功批准和部署将创造巨大的商业机会，并使公司能够站在这一不断发展的领域的最前沿。这一趋势强调了研发投资对于满足新兴医疗需求和保持竞争力的重要性。

细分分析

预计到 2024 年，试剂细分市场将占据超过 50% 的市场占有率，并预计将保持其主导地位，在 2024 年至 2034 年的预测期内呈现出最高的复合年增长率。这种成长轨迹是由产业领导者为创新新试剂和诊断试剂盒而进行的广泛研究和开发举措所推动的。一个值得注意的例子是，2023 年 2 月，BD 在美国获得了 BD Onclarity HPV Assay 与 ThinPrep Pap Test 结合使用的市场授权。这些进展凸显了人们对旨在增强快速癌症诊断和精准医疗解决方案的研究和开发的日益重视。

本报告提供全球体外诊断的市场调查，彙整市场概要，影响市场成长因素及市场机会分析，市场规模的转变·预测，各种区分·地区/各主要国家的详细分析，竞争情形，主要企业简介等资讯。

目录

第1章 报告概要

第2章 摘要整理

第3章 市场概要

  • 主要调查结果
  • 影响分析
  • 市场推动要素
    • 慢性疾病增加
    • 对个人化医疗的需求不断增加
    • 诊断技术的进步
    • 扩大即时检测的介绍
    • 新兴国家医疗基础设施的扩建
    • 提高早期发现疾病的意识
    • 政府支持医疗改革的努力
  • 阻碍市场要素
    • 进阶诊断测试成本高昂
    • 严格的监理框架
    • 资源贫乏地区的进入限制
    • 缺乏熟练的专业人员来处理 IVD 设备
    • 新诊断测试的报销挑战
  • 市场机会
    • 将人工智慧和机器学习整合到诊断中
    • 拓展发展中地区尚未开发的市场
    • 家庭诊断的需求不断增加
    • 先进生物标誌物的开发
    • 加强诊断公司和医疗保健提供者之间的合作
    • 越来越重视预防性医疗保健策略
    • 分子诊断与基因检测的发展
  • 分子诊断
  • 血液学
  • 尿液检查
  • 其他
    • 市场规模的转变·预测:各地区
    • 市场占有率:各地区

第4章 体外诊断市场分析:各用途

  • 主要调查结果
  • 市场魅力指数
  • 市场规模的转变·预测
  • 心臟病
  • 糖尿病
  • 肿瘤
  • 感染疾病
  • 肾臟
  • 自体免疫疾病
  • 药物检验/药理基因学
  • 其他
    • 市场规模的转变·预测:各地区
    • 市场占有率:各地区

第5章 体外诊断市场分析:各终端用户

  • 主要调查结果
  • 市场魅力指数
  • 市场规模的转变·预测
  • 学术研究机关
  • 诊断实验室
  • 医院
  • 其他
    • 市场规模的转变·预测:各地区
    • 市场占有率:各地区

第6章 体外诊断市场分析:各地区

  • 主要调查结果
  • 市场规模的转变·预测

第7章 北美的体外诊断市场分析

第8章 欧洲的体外诊断市场分析

第9章 亚太地区的体外诊断市场分析

第10章 南美的体外诊断市场分析

第11章 中东·非洲的体外诊断市场分析

第12章 企业简介

  • QIAGEN
  • BD
  • BioMerieux SA
  • F. Hoffmann-La Roche, Ltd.
  • Quidel
  • Ortho Corporation
  • Abbott
  • Agilent Technologies, Inc.
  • Thermofisher Scientific, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Sysmex Corporation
  • Charles River Laboratories
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • Hologic
  • Revvity
  • Exact Sciences
  • Company20

第13章 总论·建议

  • Visiongain的总论
  • 市场参与企业的建议
Product Code: PHA1360

The global In Vitro Diagnostics market is projected to grow at a CAGR of 6.7% by 2034

The In Vitro Diagnostics Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Technological Advancements Propelling Industry Growth

The surge in precision, portability, and affordability of diagnostic technologies is significantly driving growth in the market. The global adoption of innovative in-vitro diagnostic (IVD) tests is gaining momentum, fuelled by the introduction of advanced and highly accurate clinical laboratory tests. For instance, in June 2023, Japan's Ministry of Health, Labour, and Welfare granted approval for Toray Industries, Inc.'s Toray APOA2-iTQ, a diagnostic tool for pancreatic cancer. Likewise, in March 2023, the U.S. FDA approved Abbott's pioneering blood test for Traumatic Brain Injury (TBI). The successful approval and deployment of such cutting-edge IVD tests for critical health conditions are poised to unlock substantial commercial opportunities, positioning companies at the forefront of this evolving landscape. This trend underscores the importance of investing in research and development to remain competitive and responsive to emerging healthcare needs.

Segment Analysis

In 2024, the reagents segment is projected to hold over 50% of the market share, and is expected to maintain its dominance with the highest compound annual growth rate (CAGR) projected from 2024 to 2034. This growth trajectory is driven by extensive research and development initiatives undertaken by major industry players to innovate novel reagents and diagnostic kits. A noteworthy example is BD's market authorization in February 2023 for the BD Onclarity HPV Assay, which is used in conjunction with the ThinPrep Pap Test in the United States. Such advancements underscore the increasing emphasis on research and development aimed at enhancing rapid cancer diagnostics and precision medicine solutions, allowing companies to capitalize on specialized and lucrative niches within the in-vitro diagnostics (IVD) sector.

Additionally, in March 2023, QIAGEN entered into a collaboration with Servier to develop a companion diagnostic test for TIBSOVO, designed for treating acute myeloid leukaemia. This partnership exemplifies the industry's heightened focus on precision medicine, which is driving demand for innovative reagents and consumables. As the field of precision medicine continues to evolve, the need for novel products is expected to grow, positioning the reagents segment as a critical catalyst for market expansion. Companies that invest in this area will be well-positioned to lead in the competitive landscape of IVD solutions.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the in vitro diagnostics market evolving?
  • What is driving and restraining the in vitro diagnostics market?
  • How will each in vitro diagnostics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each in vitro diagnostics submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading in vitro diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the in vitro diagnostics projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of
  • in vitro diagnostics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the in vitro diagnostics market?
  • Where is the in vitro diagnostics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the in vitro diagnostics market today, and over the next 10 years:

  • Our 367-page report provides 134 tables and 185 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2034 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

  • Product
  • Instruments
  • Reagents & Kits
  • Test
  • Clinical Chemistry
  • Immunoassay/Immunochemistry
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Others
  • Application
  • Cardiology
  • Diabetes
  • Oncology
  • Infectious Diseases
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing/Pharmacogenomics
  • Others
  • End-users
  • Academic & Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles for some of the leading companies in the In Vitro Diagnostics Market, 2024 to 2034, with a focus on this segment of these companies'operations.

  • Leading companies and the potential for market growth
  • QIAGEN
  • BD
  • BioMerieux SA
  • F. Hoffmann-La Roche, Ltd.
  • Quidel
  • Ortho Corporation
  • Abbott
  • Agilent Technologies, Inc.
  • Thermofisher Scientific, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Sysmex Corporation
  • Charles River Laboratories
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • Hologic
  • Revvity
  • Exact Sciences

Overall world revenue for In Vitro Diagnostics Market, 2024 to 2034 in terms of value the market will surpass US$100 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the In Vitro Diagnostics Market, 2024 to 2034 report help you?
  • In summary, our 360+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for In Vitro Diagnostics Market 2024 to 2034, with forecasts for Product, Test, Application, and End-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the In Vitro Diagnostics Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 19 of the major companies involved in the In Vitro Diagnostics Market, 2024 to 2034.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
  • Information found nowhere else
  • With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the In Vitro Diagnostics Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to In Vitro Diagnostics Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Impact Analysis
  • 3.3 Market Driving Factors
    • 3.3.1 Increasing Prevalence of Chronic Diseases
    • 3.3.2 Rising Demand for Personalized Medicine
    • 3.3.3 Advancements in Diagnostic Technologies
    • 3.3.4 Growing Adoption of Point-of-Care Testing
    • 3.3.5 Expanding Healthcare Infrastructure in Emerging Economies
    • 3.3.6 Rising Awareness About Early Disease Detection
    • 3.3.7 Government Initiatives Supporting Healthcare Reforms
  • 3.4 Market Restraining Factors
    • 3.4.1 High Costs of Advanced Diagnostic Tests
    • 3.4.2 Stringent Regulatory Frameworks
    • 3.4.3 Limited Accessibility in Low-resource Regions
    • 3.4.4 Shortage of Skilled Professionals for Handling IVD Devices
    • 3.4.5 Reimbursement Challenges for Novel Diagnostic Tests
  • 3.5 Market Opportunities
    • 3.5.1 Integration of AI and Machine Learning in Diagnostics
    • 3.5.2 Expansion into Untapped Markets in Developing Regions
    • 3.5.3 Growing Demand for Home-based Diagnostics
    • 3.5.4 Development of Advanced Biomarkers
    • 3.5.5 Increasing Collaborations Between Diagnostic Companies and Healthcare Providers
    • 3.5.6 Rising Focus on Preventive Healthcare Strategies
    • 3.5.7 Growth in Molecular Diagnostics and Genetic Testing
  • 3.6 Molecular Diagnostics
    • 3.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 3.6.2 Market Share by Region, 2024 & 2034 (%)
  • 3.7 Hematology
    • 3.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 3.7.2 Market Share by Region, 2024 & 2034 (%)
  • 3.8 Urinalysis
    • 3.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 3.8.2 Market Share by Region, 2024 & 2034 (%)
  • 3.9 Others
    • 3.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 3.9.2 Market Share by Region, 2024 & 2034 (%)

4 In Vitro Diagnostics Market Analysis by Application

  • 4.1 Key Findings
  • 4.2 Application Segment: Market Attractiveness Index
  • 4.3 In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 4.4 Cardiology
    • 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Diabetes
    • 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Oncology
    • 4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Infectious Diseases
    • 4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8 Nephrology
    • 4.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9 Autoimmune Diseases
    • 4.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.9.2 Market Share by Region, 2024 & 2034 (%)
  • 4.10 Drug Testing/Pharmacogenomics
    • 4.10.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.10.2 Market Share by Region, 2024 & 2034 (%)
  • 4.11 Others
    • 4.11.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.11.2 Market Share by Region, 2024 & 2034 (%)

5 In Vitro Diagnostics Market Analysis by End-users

  • 5.1 Key Findings
  • 5.2 End-users Segment: Market Attractiveness Index
  • 5.3 In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 5.4 Academic & Research Institutes
    • 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Diagnostic Laboratories
    • 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Hospitals
    • 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 Others
    • 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)

6 In Vitro Diagnostics Market Analysis by Region

  • 6.1 Key Findings
  • 6.2 Regional Market Size Estimation and Forecast

7 North America In Vitro Diagnostics Market Analysis

  • 7.1 Key Findings
  • 7.2 North America In Vitro Diagnostics Market Attractiveness Index
  • 7.3 North America In Vitro Diagnostics Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 7.4 North America In Vitro Diagnostics Market Size Estimation and Forecast by Country
  • 7.5 North America In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 7.6 North America In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 7.7 North America In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 7.8 North America In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 7.9 U.S. In Vitro Diagnostics Market Analysis
  • 7.10 Canada In Vitro Diagnostics Market Analysis

8 Europe In Vitro Diagnostics Market Analysis

  • 8.1 Key Findings
  • 8.2 Europe In Vitro Diagnostics Market Attractiveness Index
  • 8.3 Europe In Vitro Diagnostics Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 8.4 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Country
  • 8.5 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 8.6 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 8.7 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 8.8 Europe In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 8.9 Germany In Vitro Diagnostics Market Analysis
  • 8.10 UK In Vitro Diagnostics Market Analysis
  • 8.11 France In Vitro Diagnostics Market Analysis
  • 8.12 Italy In Vitro Diagnostics Market Analysis
  • 8.13 Spain In Vitro Diagnostics Market Analysis
  • 8.14 Russia In Vitro Diagnostics Market Analysis
  • 8.15 Rest of Europe In Vitro Diagnostics Market Analysis

9 Asia Pacific In Vitro Diagnostics Market Analysis

  • 9.1 Key Findings
  • 9.2 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
  • 9.3 Asia Pacific In Vitro Diagnostics Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 9.4 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Country
  • 9.5 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 9.6 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 9.7 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 9.8 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 9.9 Japan In Vitro Diagnostics Market Analysis
  • 9.10 China In Vitro Diagnostics Market Analysis
  • 9.11 India In Vitro Diagnostics Market Analysis
  • 9.12 Australia In Vitro Diagnostics Market Analysis
  • 9.13 South Korea In Vitro Diagnostics Market Analysis
  • 9.14 Rest of Asia Pacific In Vitro Diagnostics Market Analysis

10 Latin America In Vitro Diagnostics Market Analysis

  • 10.1 Key Findings
  • 10.2 Latin America In Vitro Diagnostics Market Attractiveness Index
  • 10.3 Latin America In Vitro Diagnostics Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Country
  • 10.5 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 10.6 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 10.7 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 10.8 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 10.9 Brazil In Vitro Diagnostics Market Analysis
  • 10.10 Mexico In Vitro Diagnostics Market Analysis
  • 10.11 Argentina In Vitro Diagnostics Market Analysis
  • 10.12 Colombia In Vitro Diagnostics Market Analysis
  • 10.13 Rest of Latin America In Vitro Diagnostics Market Analysis

11 MEA In Vitro Diagnostics Market Analysis

  • 11.1 Key Findings
  • 11.2 MEA In Vitro Diagnostics Market Attractiveness Index
  • 11.3 MEA In Vitro Diagnostics Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Country
  • 11.5 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 11.6 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 11.7 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 11.8 MEA In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 11.9 GCC In Vitro Diagnostics Market Analysis
  • 11.10 South Africa In Vitro Diagnostics Market Analysis
  • 11.11 Rest of MEA In Vitro Diagnostics Market Analysis

12 Company Profiles

  • 12.1 QIAGEN
    • 12.1.1 Company Snapshot
    • 12.1.2 Company Overview
    • 12.1.3 Company Financials
      • 12.1.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.1.3.2 R&D, 2021-2023 (US$ Million)
      • 12.1.3.3 Regional Shares, 2023 (%)
      • 12.1.3.4 Business Segment Market Shares, 2023 (%)
    • 12.1.4 Product Benchmarking
    • 12.1.5 Strategic Outlook
  • 12.2 BD
    • 12.2.1 Company Snapshot
    • 12.2.2 Company Overview
    • 12.2.3 Company Financials
      • 12.2.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.2.3.2 R&D, 2021-2023 (US$ Million)
      • 12.2.3.3 Regional Shares, 2023 (%)
      • 12.2.3.4 Business Segment Market Shares, 2023 (%)
    • 12.2.4 Product Benchmarking
    • 12.2.5 Strategic Outlook
  • 12.3 BioMerieux SA
    • 12.3.1 Company Snapshot
    • 12.3.2 Company Overview
    • 12.3.3 Company Financials
      • 12.3.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.3.3.2 R&D, 2021-2023 (US$ Million)
      • 12.3.3.3 Regional Shares, 2023 (%)
      • 12.3.3.4 Business Segment Market Shares, 2023 (%)
    • 12.3.4 Product Benchmarking
    • 12.3.5 Strategic Outlook
  • 12.4 F. Hoffmann-La Roche, Ltd.
    • 12.4.1 Company Snapshot
    • 12.4.2 Company Overview
    • 12.4.3 Company Financials
      • 12.4.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.4.3.2 R&D, 2021-2023 (US$ Million)
      • 12.4.3.3 Regional Shares, 2023 (%)
      • 12.4.3.4 Business Segment Market Shares, 2023 (%)
    • 12.4.4 Product Benchmarking
    • 12.4.5 Strategic Outlook
  • 12.5 Quidel
    • 12.5.1 Company Snapshot
    • 12.5.2 Company Overview
    • 12.5.3 Company Financials
      • 12.5.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.5.3.2 R&D, 2021-2023 (US$ Million)
      • 12.5.3.3 Regional Shares, 2023 (%)
      • 12.5.3.4 Business Segment Market Shares, 2023 (%)
    • 12.5.4 Product Benchmarking
    • 12.5.5 Strategic Outlook
  • 12.6 Ortho Corporation
    • 12.6.1 Company Snapshot
    • 12.6.2 Company Overview
    • 12.6.3 Company Financials
      • 12.6.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.6.3.2 R&D, 2021-2023 (US$ Million)
      • 12.6.3.3 Regional Shares, 2023 (%)
      • 12.6.3.4 Business Segment Market Shares, 2023 (%)
    • 12.6.4 Product Benchmarking
    • 12.6.5 Strategic Outlook
  • 12.7 Abbott
    • 12.7.1 Company Snapshot
    • 12.7.2 Company Overview
    • 12.7.3 Company Financials
      • 12.7.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.7.3.2 R&D, 2021-2023 (US$ Million)
      • 12.7.3.3 Regional Shares, 2023 (%)
      • 12.7.3.4 Business Segment Market Shares, 2023 (%)
    • 12.7.4 Product Benchmarking
    • 12.7.5 Strategic Outlook
  • 12.8 Agilent Technologies, Inc.
    • 12.8.1 Company Snapshot
    • 12.8.2 Company Overview
    • 12.8.3 Company Financials
      • 12.8.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.8.3.2 R&D, 2021-2023 (US$ Million)
      • 12.8.3.3 Regional Shares, 2023 (%)
      • 12.8.3.4 Business Segment Market Shares, 2023 (%)
    • 12.8.4 Product Benchmarking
    • 12.8.5 Strategic Outlook
  • 12.9 Thermofisher Scientific, Inc.
    • 12.9.1 Company Snapshot
    • 12.9.2 Company Overview
    • 12.9.3 Company Financials
      • 12.9.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.9.3.2 R&D, 2021-2023 (US$ Million)
      • 12.9.3.3 Regional Shares, 2023 (%)
      • 12.9.3.4 Business Segment Market Shares, 2023 (%)
    • 12.9.4 Product Benchmarking
    • 12.9.5 Strategic Outlook
  • 12.10 Siemens Healthineers AG
    • 12.10.1 Company Snapshot
    • 12.10.2 Company Overview
    • 12.10.3 Company Financials
      • 12.10.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.10.3.2 R&D, 2021-2023 (US$ Million)
      • 12.10.3.3 Regional Shares, 2023 (%)
      • 12.10.3.4 Business Segment Market Shares, 2023 (%)
    • 12.10.4 Product Benchmarking
    • 12.10.5 Strategic Outlook
  • 12.11 Bio-Rad Laboratories, Inc.
    • 12.11.1 Company Snapshot
    • 12.11.2 Company Overview
    • 12.11.3 Company Financials
      • 12.11.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.11.3.2 R&D, 2021-2023 (US$ Million)
      • 12.11.3.3 Regional Shares, 2023 (%)
      • 12.11.3.4 Business Segment Market Shares, 2023 (%)
    • 12.11.4 Product Benchmarking
    • 12.11.5 Strategic Outlook
  • 12.12 Danaher
    • 12.12.1 Company Snapshot
    • 12.12.2 Company Overview
    • 12.12.3 Company Financials
      • 12.12.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.12.3.2 R&D, 2021-2023 (US$ Million)
      • 12.12.3.3 Regional Shares, 2023 (%)
      • 12.12.3.4 Business Segment Market Shares, 2023 (%)
    • 12.12.4 Product Benchmarking
    • 12.12.5 Strategic Outlook
  • 12.13 Sysmex Corporation
    • 12.13.1 Company Snapshot
    • 12.13.2 Company Overview
    • 12.13.3 Company Financials
      • 12.13.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.13.3.2 R&D, 2021-2023 (US$ Million)
      • 12.13.3.3 Regional Shares, 2023 (%)
      • 12.13.3.4 Business Segment Market Shares, 2023 (%)
    • 12.13.4 Product Benchmarking
    • 12.13.5 Strategic Outlook
  • 12.14 Charles River Laboratories
    • 12.14.1 Company Snapshot
    • 12.14.2 Company Overview
    • 12.14.3 Company Financials
      • 12.14.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.14.3.2 R&D, 2021-2023 (US$ Million)
      • 12.14.3.3 Regional Shares, 2023 (%)
      • 12.14.3.4 Business Segment Market Shares, 2023 (%)
    • 12.14.4 Product Benchmarking
    • 12.14.5 Strategic Outlook
  • 12.15 Quest Diagnostics Incorporated
    • 12.15.1 Company Snapshot
    • 12.15.2 Company Overview
    • 12.15.3 Company Financials
      • 12.15.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.15.3.2 R&D, 2021-2023 (US$ Million)
      • 12.15.3.3 Regional Shares, 2023 (%)
      • 12.15.3.4 Business Segment Market Shares, 2023 (%)
    • 12.15.4 Product Benchmarking
    • 12.15.5 Strategic Outlook
  • 12.16 Illumina, Inc.
    • 12.16.1 Company Snapshot
    • 12.16.2 Company Overview
    • 12.16.3 Company Financials
      • 12.16.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.16.3.2 R&D, 2021-2023 (US$ Million)
      • 12.16.3.3 Regional Shares, 2023 (%)
      • 12.16.3.4 Business Segment Market Shares, 2023 (%)
    • 12.16.4 Product Benchmarking
    • 12.16.5 Strategic Outlook
  • 12.17 Hologic
    • 12.17.1 Company Snapshot
    • 12.17.2 Company Overview
    • 12.17.3 Company Financials
      • 12.17.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.17.3.2 R&D, 2021-2023 (US$ Million)
      • 12.17.3.3 Regional Shares, 2023 (%)
      • 12.17.3.4 Business Segment Market Shares, 2023 (%)
    • 12.17.4 Product Benchmarking
    • 12.17.5 Strategic Outlook
  • 12.18 Revvity
    • 12.18.1 Company Snapshot
    • 12.18.2 Company Overview
    • 12.18.3 Company Financials
      • 12.18.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.18.3.2 R&D, 2021-2023 (US$ Million)
      • 12.18.3.3 Regional Shares, 2023 (%)
      • 12.18.3.4 Business Segment Market Shares, 2023 (%)
    • 12.18.4 Product Benchmarking
    • 12.18.5 Strategic Outlook
  • 12.19 Exact Sciences
    • 12.19.1 Company Snapshot
    • 12.19.2 Company Overview
    • 12.19.3 Company Financials
      • 12.19.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.19.3.2 R&D, 2021-2023 (US$ Million)
      • 12.19.3.3 Regional Shares, 2023 (%)
      • 12.19.3.4 Business Segment Market Shares, 2023 (%)
    • 12.19.4 Product Benchmarking
    • 12.19.5 Strategic Outlook
  • 12.20 Company20
    • 12.20.1 Company Snapshot
    • 12.20.2 Company Overview
    • 12.20.3 Company Financials
      • 12.20.3.1 Revenue, 2021-2023 (US$ Million)
      • 12.20.3.2 R&D, 2021-2023 (US$ Million)
      • 12.20.3.3 Regional Shares, 2023 (%)
      • 12.20.3.4 Business Segment Market Shares, 2023 (%)
    • 12.20.4 Product Benchmarking
    • 12.20.5 Strategic Outlook

13 Conclusion and Recommendations

  • 13.1 Concluding Remarks from Visiongain
  • 13.2 Recommendations for Market Players

List of Tables

  • Table 1 In Vitro Diagnostics Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
  • Table 2 In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 3 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 4 Reagents & Kits Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 5 In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 6 Clinical Chemistry Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 7 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 8 Molecular Diagnostics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 9 Hematology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 10 Urinalysis Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 11 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 12 In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 13 Cardiology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 14 Diabetes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 15 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 16 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 17 Nephrology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 18 Autoimmune Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 19 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 20 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 21 In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 22 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 23 Diagnostic Laboratories Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 24 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 25 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 26 In Vitro Diagnostics Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 27 North America In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 28 North America In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 29 North America In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 30 North America In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 31 North America In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 32 U.S. In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 33 Canada In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 34 Europe In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 35 Europe In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 36 Europe In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 37 Europe In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 38 Europe In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 39 Germany In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 40 UK In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 41 France In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 42 Italy In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 43 Spain In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 44 Russia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 45 Rest of Europe In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 46 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 47 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 48 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 49 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 50 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 51 Japan In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 52 China In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 53 India In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 54 Australia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 55 South Korea In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 56 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 57 Latin America In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 58 Latin America In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 59 Latin America In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 60 Latin America In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 61 Latin America In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 62 Brazil In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 63 Mexico In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 64 Argentina In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 65 Colombia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 66 Rest of Latin America In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 67 MEA In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 68 MEA In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 69 MEA In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 70 MEA In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 71 MEA In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 72 GCC In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 73 South Africa In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 74 Rest of MEA In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 75 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 76 QIAGEN: Product Benchmarking
  • Table 77 QIAGEN: Strategic Outlook
  • Table 78 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 BD: Product Benchmarking
  • Table 80 BD: Strategic Outlook
  • Table 81 BioMerieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 BioMerieux SA: Product Benchmarking
  • Table 83 BioMerieux SA: Strategic Outlook
  • Table 84 F. Hoffmann-La Roche, Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 F. Hoffmann-La Roche, Ltd.: Product Benchmarking
  • Table 86 F. Hoffmann-La Roche, Ltd.: Strategic Outlook
  • Table 87 Quidel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Quidel: Product Benchmarking
  • Table 89 Quidel: Strategic Outlook
  • Table 90 Ortho Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Ortho Corporation: Product Benchmarking
  • Table 92 Ortho Corporation: Strategic Outlook
  • Table 93 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 Abbott: Product Benchmarking
  • Table 95 Abbott: Strategic Outlook
  • Table 96 Agilent Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 Agilent Technologies, Inc.: Product Benchmarking
  • Table 98 Agilent Technologies, Inc.: Strategic Outlook
  • Table 99 Thermofisher Scientific, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 Thermofisher Scientific, Inc.: Product Benchmarking
  • Table 101 Thermofisher Scientific, Inc.: Strategic Outlook
  • Table 102 Siemens Healthineers AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 103 Siemens Healthineers AG: Product Benchmarking
  • Table 104 Siemens Healthineers AG: Strategic Outlook
  • Table 105 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 Bio-Rad Laboratories, Inc.: Product Benchmarking
  • Table 107 Bio-Rad Laboratories, Inc.: Strategic Outlook
  • Table 108 Danaher: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Danaher: Product Benchmarking
  • Table 110 Danaher: Strategic Outlook
  • Table 111 Sysmex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 112 Sysmex Corporation: Product Benchmarking
  • Table 113 Sysmex Corporation: Strategic Outlook
  • Table 114 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 Charles River Laboratories: Product Benchmarking
  • Table 116 Charles River Laboratories: Strategic Outlook
  • Table 117 Quest Diagnostics Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 Quest Diagnostics Incorporated: Product Benchmarking
  • Table 119 Quest Diagnostics Incorporated: Strategic Outlook
  • Table 120 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 121 Illumina, Inc.: Product Benchmarking
  • Table 122 Illumina, Inc.: Strategic Outlook
  • Table 123 Hologic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 124 Hologic: Product Benchmarking
  • Table 125 Hologic: Strategic Outlook
  • Table 126 Revvity: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 127 Revvity: Product Benchmarking
  • Table 128 Revvity: Strategic Outlook
  • Table 129 Exact Sciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 130 Exact Sciences: Product Benchmarking
  • Table 131 Exact Sciences: Strategic Outlook
  • Table 132 Company20: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 133 Company20: Product Benchmarking
  • Table 134 Company20: Strategic Outlook

List of Figures

  • Figure 1 In Vitro Diagnostics Market Segmentation
  • Figure 2 In Vitro Diagnostics Market by Product: Market Attractiveness Index
  • Figure 3 In Vitro Diagnostics Market by Test: Market Attractiveness Index
  • Figure 4 In Vitro Diagnostics Market by Application: Market Attractiveness Index
  • Figure 5 In Vitro Diagnostics Market by End-users: Market Attractiveness Index
  • Figure 6 In Vitro Diagnostics Market Attractiveness Index by Region
  • Figure 7 In Vitro Diagnostics Market: Market Dynamics
  • Figure 8 In Vitro Diagnostics Market: Porter's Five Forces Analysis
  • Figure 9 In Vitro Diagnostics Market: PEST Analysis
  • Figure 10 In Vitro Diagnostics Market Attractiveness Index by Product
  • Figure 11 In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
  • Figure 12 In Vitro Diagnostics Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 13 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 14 Instruments Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 15 Reagents & Kits Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 16 Reagents & Kits Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 17 In Vitro Diagnostics Market Attractiveness Index by Test
  • Figure 18 In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
  • Figure 19 In Vitro Diagnostics Market Share Forecast by Test, 2024, 2029, 2034 (%)
  • Figure 20 Clinical Chemistry Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 21 Clinical Chemistry Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 22 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 23 Immunoassay/Immunochemistry Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 24 Molecular Diagnostics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 25 Molecular Diagnostics Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 26 Hematology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 27 Hematology Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 28 Urinalysis Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 29 Urinalysis Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 30 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 31 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 32 In Vitro Diagnostics Market Attractiveness Index by Application
  • Figure 33 In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 34 In Vitro Diagnostics Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 35 Cardiology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 36 Cardiology Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 37 Diabetes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 38 Diabetes Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 39 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 40 Oncology Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 41 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 42 Infectious Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 43 Nephrology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 44 Nephrology Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 45 Autoimmune Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 46 Autoimmune Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 47 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 48 Drug Testing/Pharmacogenomics Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 49 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 50 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 51 In Vitro Diagnostics Market Attractiveness Index by End-users
  • Figure 52 In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 53 In Vitro Diagnostics Market Share Forecast by End-users, 2024, 2029, 2034 (%)
  • Figure 54 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 55 Academic & Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 56 Diagnostic Laboratories Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 57 Diagnostic Laboratories Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 58 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 59 Hospitals Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 60 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 61 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 62 In Vitro Diagnostics Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
  • Figure 63 In Vitro Diagnostics Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 64 In Vitro Diagnostics Market by Region, 2024-2034 (US$ Bn, AGR %)
  • Figure 65 North America In Vitro Diagnostics Market Attractiveness Index
  • Figure 66 North America In Vitro Diagnostics Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 67 North America In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 68 North America In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
  • Figure 69 North America In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
  • Figure 70 North America In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 71 North America In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 72 U.S. In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 73 Canada In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 74 Europe In Vitro Diagnostics Market Attractiveness Index
  • Figure 75 Europe In Vitro Diagnostics Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 76 Europe In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 77 Europe In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
  • Figure 78 Europe In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
  • Figure 79 Europe In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 80 Europe In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 81 Germany In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 82 UK In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 83 France In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 84 Italy In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 85 Spain In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 86 Russia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 87 Rest of Europe In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 88 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
  • Figure 89 Asia Pacific In Vitro Diagnostics Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 90 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 91 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
  • Figure 92 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
  • Figure 93 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 94 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 95 Japan In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 96 China In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 97 India In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 98 Australia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 99 South Korea In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 100 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 101 Latin America In Vitro Diagnostics Market Attractiveness Index
  • Figure 102 Latin America In Vitro Diagnostics Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 103 Latin America In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 104 Latin America In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
  • Figure 105 Latin America In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
  • Figure 106 Latin America In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 107 Latin America In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 108 Brazil In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 109 Mexico In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 110 Argentina In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 111 Colombia In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 112 Rest of Latin America In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 113 MEA In Vitro Diagnostics Market Attractiveness Index
  • Figure 114 MEA In Vitro Diagnostics Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 115 MEA In Vitro Diagnostics Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 116 MEA In Vitro Diagnostics Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
  • Figure 117 MEA In Vitro Diagnostics Market Forecast by Test, 2024-2034 (US$ Billion, AGR %)
  • Figure 118 MEA In Vitro Diagnostics Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 119 MEA In Vitro Diagnostics Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 120 GCC In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 121 South Africa In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 122 Rest of MEA In Vitro Diagnostics Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 123 QIAGEN: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 124 QIAGEN: Regional Market Shares (%), 2023
  • Figure 125 QIAGEN: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 126 QIAGEN: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 127 QIAGEN: Regional Market Shares (%), 2023
  • Figure 128 QIAGEN: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 129 BD: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 130 BD: Regional Market Shares (%), 2023
  • Figure 131 BD: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 132 BioMerieux SA: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 133 BioMerieux SA: Regional Market Shares (%), 2023
  • Figure 134 BioMerieux SA: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 135 F. Hoffmann-La Roche, Ltd.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 136 F. Hoffmann-La Roche, Ltd.: Regional Market Shares (%), 2023
  • Figure 137 F. Hoffmann-La Roche, Ltd.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 138 Quidel: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 139 Quidel: Regional Market Shares (%), 2023
  • Figure 140 Quidel: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 141 Ortho Corporation: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 142 Ortho Corporation: Regional Market Shares (%), 2023
  • Figure 143 Ortho Corporation: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 144 Abbott: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 145 Abbott: Regional Market Shares (%), 2023
  • Figure 146 Abbott: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 147 Agilent Technologies, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 148 Agilent Technologies, Inc.: Regional Market Shares (%), 2023
  • Figure 149 Agilent Technologies, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 150 Thermofisher Scientific, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 151 Thermofisher Scientific, Inc.: Regional Market Shares (%), 2023
  • Figure 152 Thermofisher Scientific, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 153 Siemens Healthineers AG: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 154 Siemens Healthineers AG: Regional Market Shares (%), 2023
  • Figure 155 Siemens Healthineers AG: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 156 Bio-Rad Laboratories, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 157 Bio-Rad Laboratories, Inc.: Regional Market Shares (%), 2023
  • Figure 158 Bio-Rad Laboratories, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 159 Danaher: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 160 Danaher: Regional Market Shares (%), 2023
  • Figure 161 Danaher: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 162 Sysmex Corporation: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 163 Sysmex Corporation: Regional Market Shares (%), 2023
  • Figure 164 Sysmex Corporation: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 165 Charles River Laboratories: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 166 Charles River Laboratories: Regional Market Shares (%), 2023
  • Figure 167 Charles River Laboratories: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 168 Quest Diagnostics Incorporated: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 169 Quest Diagnostics Incorporated: Regional Market Shares (%), 2023
  • Figure 170 Quest Diagnostics Incorporated: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 171 Illumina, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 172 Illumina, Inc.: Regional Market Shares (%), 2023
  • Figure 173 Illumina, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 174 Hologic: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 175 Hologic: Regional Market Shares (%), 2023
  • Figure 176 Hologic: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 177 Revvity: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 178 Revvity: Regional Market Shares (%), 2023
  • Figure 179 Revvity: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 180 Exact Sciences: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 181 Exact Sciences: Regional Market Shares (%), 2023
  • Figure 182 Exact Sciences: R&D, 2021-2023 (US$ Million, AGR %)
  • Figure 183 Company20: Net Revenue, 2021-2023 (US$ Million, AGR %)
  • Figure 184 Company20: Regional Market Shares (%), 2023
  • Figure 185 Company20: R&D, 2021-2023 (US$ Million, AGR %)